Join our subscribers
ImmuniWeb Neuron web security scanning
Friday, June 10, 2022
ImmuniWeb has announced the launch of ImmuniWeb Neuron, a web application and API web security scanning solution that is based on the award-winning ImmuniWeb AI Platform available.
ImmuniWeb Neuron is designed to rapidly scan tens, hundreds, or even thousands of web applications and APIs for vulnerabilities, weaknesses, and misconfigurations. It can be natively integrated into a CI/CD pipeline, enabling 100% automation of application security, privacy, and compliance testing prior to deploying new code into a production environment. The entire process of web scan configuration, scheduling, and management is fully automated and can be performed by users in a few clicks.
The award-winning ImmuniWeb AI Platform provides enterprise customers from over 50 countries with web, mobile, and API penetration testing services in the rapidly growing global application security market, which is projected to reach $12.9 billion in two years. ImmuniWeb pioneered with practical usage of Machine Learning and AI for intelligent automation and acceleration of time-consuming tasks and processes and has been recognized for its innovation by market analysts from Gartner, Forrester, and IDC.
AI-driven ImmuniWeb Neuron brings intelligent automation to the web security scanning market
ImmuniWeb Neuron leverages ImmuniWeb's proprietary Machine Learning engine to detect more vulnerabilities and provide a zero false-positives SLA corroborated with a contractual moneyback guarantee if a single false positive is spotted in a report. Moreover, every license is equipped with 24/7 technical support available via ticketing or by email if software developers or DevOps engineers have questions or need assistance.
By adding fully automated web and API security scanning to its offering, ImmuniWeb becomes the only platform to comprehensively address security for the entire application stack in multi-cloud, on-premise, and hybrid environments, all via a flexible SaaS subscription.
Combined with ImmuniWeb Discovery for external Attack Surface Management, ImmuniWeb Neuron ensures that no single application, API, or web service remains unknown or untested. When enhanced with the firm's Cyber Threat Intelligence and Dark Web Monitoring capabilities, ImmuniWeb Neuron brings additional certainty that sophisticated phishing campaigns or password spraying attacks will not ruin your application security efforts.
ImmuniWeb AI Platform now offers 5 mutually enhancing and complementary products with 20 use cases, including GDPR penetration testing, web security scanning, cyber threat intelligence, and network security assessments.
For application penetration testing, required by numerous security standards and laws such as PCI DSS and GDPR, ImmuniWeb continues offering a full spectrum of web, mobile, and API penetration testing solutions accredited by CREST.
Ilia Kolochenko, Chief Architect & CEO at ImmuniWeb, says: "ImmuniWeb Neuron is a major milestone for the ImmuniWeb AI Platform that now provides a full spectrum of web application security testing of any type and complexity.
Designed both for large enterprise customers and SMEs, ImmuniWeb Neuron provides simplicity, agility, and cost-efficiency, taking your application security program to the next level. Combined with other products available on our award-winning Platform, ImmuniWeb Neuron comprehensively addresses emerging risks, novel threats, and attack vectors in a holistic manner.
We are grateful to all our customers and partners around the globe that inspire us to work hard and relentlessly innovate to deliver value and excellence. More exciting announcements are coming soon, please stay tuned."
Online sales of ImmuniWeb Neuron are scheduled to start on July 4, 2022, however, product demos and trials are already available as of today. Webinars for customers and partners will be announced soon. Read Full Article
Tech Wire Asia: Google loses defamation fight in Australia
